Since the cyclin E1 degradation machinery was deregulated in BRCA1 mutant cancers across our cohort, we investigated whether cyclin E1 turnover is dysregulated in cell lines with mutant BRCA1 or BRCA1 loss. Here, BRCA1 is linked to cancer.